McCormick, Delta Apparel And 3 Stocks To Watch Heading Into Tuesday

10/3/23 4:13:01 AM ET

Farming/Seeds/Milling

Consumer Staples

Apparel

Consumer Staples

Get the next $CALM alert in real time by email

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Wall Street expects McCormick & Company, Incorporated (NYSE:MKC) to report quarterly earnings at 65 cents per share on revenue of $1.70 billion before the opening bell. McCormick shares fell 0.1% to $74.70 in after-hours trading.

Delta Apparel, Inc. (NYSE:DLA) said it received an unsolicited offer to purchase its Salt Life business. Delta Apparel shares jumped 19.9% to $7.90 in the after-hours trading session.

Analysts are expecting Cal-Maine Foods, Inc. (NASDAQ:CALM) to have earned 25 cents per share on revenue of $473.37 million for the latest quarter. The company will release earnings after the markets close. Cal-Maine shares fell 0.7% to $47.20 in after-hours trading.

Check out our premarket coverage here

Gaia, Inc. (NYSE:GAIA) reported a proposed public offering of common stock. Gaia shares fell 2.3% to $2.60 in the after-hours trading session.

Analysts expect Trinity Biotech plc (NASDAQ:TRIB) to post a quarterly loss at 9 cents per share on revenue of $13.50 million before the opening bell. Trinity Biotech shares fell 3.9% to close at $0.70 on Monday.

Read This Next: Top 3 Risk Off Stocks That May Crash In Q4

Get the next $CALM alert in real time by email

Crush Q1 2026 with the Best AI Superconnector

Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

AI-Powered Inbox

Context-aware email replies

Strategic Decision Support

Get Started with Standout.work

Recent Analyst Ratings for
$CALM
$DLA
$GAIA
$MKC

Company	Date	Price Target	Rating	Analyst
McCormick & Company Incorporated $MKC	12/15/2025	$75.00	Hold → Buy	Deutsche Bank
Cal-Maine Foods Inc. $CALM	12/1/2025	$100.00	Buy	The Benchmark Company
McCormick & Company Incorporated $MKC	8/20/2025	$83.00	Neutral → Overweight	Analyst
Cal-Maine Foods Inc. $CALM	8/14/2025	$110.00	Neutral	Goldman
McCormick & Company Incorporated $MKC	6/16/2025	$83.00	Neutral	UBS
Cal-Maine Foods Inc. $CALM	5/6/2025	$100.00	Market Perform	BMO Capital Markets
McCormick & Company Incorporated $MKC	3/27/2025		Buy → Hold	Argus
Gaia Inc. $GAIA	2/11/2025	$10.00	Buy	ROTH MKM

More analyst ratings

$CALM
$DLA
$GAIA
$MKC
Press Releases

Fastest customizable press release news feed in the world

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

DUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice on February 19, 2026 from the Nasdaq Stock Market LLC ("Nasdaq") that the Company no longer meets the requirement in Nasdaq Listing Rule 5450(b) that listed securities maintain a minimum market value of publicly held shares ("MVPHS") of $15,000,000, based on Nasdaq's review of the Company's MVPHS for the last 30 consecutive business days. This notice has no immediate effect on the listing of the Company's ADSs, which will continue to trade at this time on the Nas

2/20/26 5:00:00 PM ET

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Health Care

Gaia Sets Fourth Quarter and Full Year 2025 Conference Call for Monday, March 2, 2026, at 4:30 p.m. ET

BOULDER, Colo., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ:GAIA), a conscious media and community company, will conduct a conference call on Monday, March 2, 2026, at 4:30 p.m. Eastern time (2:30 p.m. Mountain time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. The company will report its financial results in a press release prior to the call. Gaia management will host the conference call, followed by a question and answer period. Date: Monday, March 2, 2026Time: 4:30 p.m. Eastern time (2:30 p.m. Mountain time)Toll-free dial-in number: 1-877-269-7751International dial-in number: 1-201-389-0908Conference ID: 13758211 Please call

2/17/26 8:30:00 AM ET

Movies/Entertainment

Consumer Discretionary

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement

DUBLIN, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice on February 11, 2026 from the Nasdaq Stock Market LLC ("Nasdaq") that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1), requiring that listed securities maintain a minimum bid price of $1.00 per share, based on the closing bid price of the Company's American Depositary Shares ("ADSs") for the last 30 consecutive business days. This notice has no immediate effect on the listing of the Company's ADSs, which will continue to trade at this time on

2/13/26 5:00:00 PM ET

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Health Care

$CALM
$DLA
$GAIA
$MKC
Leadership Updates

Live Leadership Updates

McCormick Appoints Gavin Hattersley and Rick Dierker to Board of Directors

HUNT VALLEY, Md., Jan. 21, 2026 /PRNewswire/ -- McCormick & Company, Incorporated (NYSE:MKC), a global leader in flavor, today announced that Gavin Hattersley, retired President and Chief Executive Officer of Molson Coors Beverage Company, and Rick Dierker, President and Chief Executive Officer of Church & Dwight Co., Inc., have been appointed to McCormick's Board of Directors effective February 1, 2026. Mr. Hattersley brings more than 35 years of leadership experience spanning the global consumer packaged goods and beverage industries. Most recently, he served as President an

1/21/26 4:15:00 PM ET

Packaged Foods

Consumer Staples

Trinity Biotech Appoints Paul Tivnan as Non-Executive Director

DUBLIN, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the appointment of Paul Tivnan to its Board of Directors as a Non-Executive Director. Mr. Tivnan brings over 25 years of senior leadership experience in finance, capital markets, and corporate governance across the infrastructure, energy, shipping, and cleantech sectors. He currently serves as Chief Financial Officer of Deriva Energy LLC, one of the largest independent renewable power producers in the United States and a Brookfield portfolio company. His previous

8/21/25 9:00:23 AM ET

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Health Care

Cal-Maine Foods, Inc. Appoints Keira Lombardo as Company's First Chief Strategy Officer

Cal-Maine Foods, Inc. (NASDAQ: CALM ("Cal-Maine Foods" or the "Company"), today announced the appointment of Keira Lombardo as the Company's first-ever Chief Strategy Officer (CSO), effective today. The creation of this role underscores Cal-Maine Food's commitment to delivering long-term value through operational excellence, innovation, and deeper stakeholder engagement. As CSO, Lombardo will work with the senior leadership team to further accelerate and shape enterprise priorities—building on Cal-Maine Food's leadership role in a rapidly changing marketplace. Lombardo is a seasoned food and agriculture executive with over two decades of experience leading transformation and growth acro

8/11/25 8:00:00 AM ET

Farming/Seeds/Milling

Consumer Staples

$CALM
$DLA
$GAIA
$MKC
Financials

Live finance-specific insights

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

DUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice on February 19, 2026 from the Nasdaq Stock Market LLC ("Nasdaq") that the Company no longer meets the requirement in Nasdaq Listing Rule 5450(b) that listed securities maintain a minimum market value of publicly held shares ("MVPHS") of $15,000,000, based on Nasdaq's review of the Company's MVPHS for the last 30 consecutive business days. This notice has no immediate effect on the listing of the Company's ADSs, which will continue to trade at this time on the Nas

2/20/26 5:00:00 PM ET

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Health Care

Gaia Sets Fourth Quarter and Full Year 2025 Conference Call for Monday, March 2, 2026, at 4:30 p.m. ET

BOULDER, Colo., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ:GAIA), a conscious media and community company, will conduct a conference call on Monday, March 2, 2026, at 4:30 p.m. Eastern time (2:30 p.m. Mountain time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. The company will report its financial results in a press release prior to the call. Gaia management will host the conference call, followed by a question and answer period. Date: Monday, March 2, 2026Time: 4:30 p.m. Eastern time (2:30 p.m. Mountain time)Toll-free dial-in number: 1-877-269-7751International dial-in number: 1-201-389-0908Conference ID: 13758211 Please call

2/17/26 8:30:00 AM ET

Movies/Entertainment

Consumer Discretionary

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement

DUBLIN, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice on February 11, 2026 from the Nasdaq Stock Market LLC ("Nasdaq") that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1), requiring that listed securities maintain a minimum bid price of $1.00 per share, based on the closing bid price of the Company's American Depositary Shares ("ADSs") for the last 30 consecutive business days. This notice has no immediate effect on the listing of the Company's ADSs, which will continue to trade at this time on

2/13/26 5:00:00 PM ET

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Health Care